UBS Group »

Briacell Therapeutics Corp shares owned by UBS Group

Quarter-by-quarter ownership of Briacell Therapeutics Corp (BCTX) shares owned by UBS Group from 13F filings

Historical chart of UBS Group investment in Briacell Therapeutics Corp

Tip: Access up to 7 years of quarterly data

All positions including Briacell Therapeutics Corp held by UBS Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Briacell Therapeutics Corp by UBS Group

Quarter filed Position value Share count Share price at filing
2023-12-31 $88 15 5.87

More positions owned by UBS Group

Microsoft Corporation (MSFT)
Apple Call Option (AAPL)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Ishares Tr Russell 2000 Etf (IWM)
Amazon Call Option (AMZN)
NVIDIA Corporation (NVDA)
Ubs Group SHS (UBS)
Broadcom (AVGO)
JPMorgan Chase & Co. (JPM)
Alphabet Cap Stk Cl A (GOOGL)
Ishares Tr 20 Yr Tr Bd Etf (TLT)
Union Pacific Corporation (UNP)
Alphabet Cap Stk Cl C Put Option (GOOG)
Meta Platforms Cl A (META)

View all positions for UBS Group

Top funds holding Briacell Therapeutics Corp

Lynwood Capital Management
Torno Capital
Redmond Asset Management
K.J. Harrison & Partners
Bank Of Montreal
Onyx Bridge Wealth Group
Summit Trail Advisors
Citadel Advisors
Royal Bank of Canada
Bank of America Corporation
HighTower Advisors
TD Waterhouse Canada
Concord Wealth Partners
National Bank Of Canada /fi/
UBS Group

View all funds holding Briacell Therapeutics Corp